Dr. Dispenzieri Discusses Anti-CD38 Monoclonal Antibodies in Myeloma
June 6th 2014
Angela Dispenzieri, MD, a professor of medicine in the division of hematology at the Mayo Clinic, discusses excitement over the development of CD38-targeted monoclonal antibodies as treatments for patients with multiple myeloma.